Offering informed choice about breast screening

Journal of Medical Screening

Volumn 21, Issue 4, 2014, Pages 194-200

  Forbes, Lindsay J L ^a   Ramirez, Amanda Jane ^a   Archer, Mary ^b   Cooke, Julie ^c   Coulter, Angela ^d   Dewar, John A ^e   Entwistle, Vikki ^f   Felton, Roger ^g   Kirby, Jessica ^h   Jones, Alison ⁱ   Michell, Michael ^j   Patnick, Julietta ^k   Reed, Malcolm ^l   Richards, Mike ^m   Rule, Joanne ⁿ   Spiegelhalter, David ^o   Spika, Devon ^p   Whelehan, Patsy ^e   Wilson, Robin M ^q  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NHS Right Care Programme   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

^g FeltonWorks   (United Kingdom)

^h IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^k National Health Service Cancer Screening Programmes   (United Kingdom)

^l UNIVERSITY OF SHEFFIELD   (United Kingdom)

^m CARE QUALITY COMMISSION   (United Kingdom)

ⁿ Healthy Conversations   (United Kingdom)

^o UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^p KING'S COLLEGE LONDON   (United Kingdom)

^q Royal Marsden   (United Kingdom)

more..

Author keywords

Breast neoplasms; Choice behaviour; Consumer involvement; Health information; Mass screening

Indexed keywords

BREAST NEOPLASMS; CONSUMER; DECISION MAKING; EARLY DIAGNOSIS; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; MASS SCREENING; NATIONAL HEALTH SERVICE; UNITED KINGDOM;

BREAST NEOPLASMS; CHOICE BEHAVIOR; COMMUNICATION; CONSUMER PARTICIPATION; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; GREAT BRITAIN; HUMANS; MASS SCREENING; STATE MEDICINE;

EID: 84927660019     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141314555350     Document Type: Article

References (42)

1. Stefanek ME. Uninformed Compliance or Informed Choice? A Needed Shift in Our Approach to Cancer Screening. Journal of the National Cancer Institute 2011;103:1821-6.
2. Welch HG, Black WC. Overdiagnosis in Cancer. Journal of the National Cancer Institute 2010;102:605-13.
3. Bell RJ, Burton RC. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?-no. The Medical Journal of Australia 2012;196:17.
4. Gotzsche PC. Mammography Screening: Truth, Lies and Controversy. London: Radcliffe Publishing Ltd, 2012.
5. Marmot M, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The beneEts and harms of breast cancer screening: an independent review. The Lancet 2012;380:1778-86.
6. Department of Health. Improving Outcomes: A Strategy for Cancer. London: Department of Health, 2011.
7. Baum M, Thornton H, Gotzsche PC. Still awaiting screening facts. British Medical Journal 2010;341:c6152.
8. Bewley S. The NHS breast screening programme needs independent review. British Medical Journal 2011;343:d6894.
9. Zapka JG, Geller BM, Bulliard JL, Fracheboud J, Sancho- Garnier H, Ballard-Barbash R. Print information to inform decisions about mammography screening participation in 16 countries with population-based programs. Patient Education and Counseling 2006;63:126-37.
10. Gummersbach E, Piccoliori G, Oriol Zerbe C, et al. Are women getting relevant information about mammography screening for an informed consent: a critical appraisal of information brochures used for screening invitation in Germany, Italy, Spain and France. The European Journal of Public Health 2010;20:409-14.
11. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. British Medical Journal 2012;344:e3502.
12. Schwartz LM, Woloshin S, Fowler Jr FJ, Welch HG. Enthusiasm for cancer screening in the United States. Journal of the American Medical Association 2004;291:71-8.
13. Chamot E, Perneger TV. Misconceptions about efficacy of mammography screening: a public health dilemma. Journal of Epidemiology and Community Health 2001;55:799-803.
14. Gigerenzer G, Mata J, Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. Journal of the National Cancer Institute 2009;101:1216-20.
15. Woloshin S, Schwartz LM. How a charity oversells mammography. British Medical Journal. 2012; 345.
16. Woloshin S, Schwartz LM, Black WC, Kramer BS. Cancer Screening Campaigns - Getting Past Uninformative Persuasion.New England Journal of Medicine 2012;367:1677-9.
17. Webster P, Austoker J. Women's knowledge about breast cancer risk and their views of the purpose and implications of breast screening - a questionnaire survey. Journal of Public Health 2006;28:197-202.
18. Hersch J, Jansen J, Barratt A, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. British Medical Journal 2013;346:f158.
19. Waller J, Douglas E, Whitaker KL, Wardle J. Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. British Medical Journal Open. 2013; 3.
20. Davey C, White V, Warne C, Kitchen P, Villanueva E, Erbas B. Understanding a ductal carcinoma in situ diagnosis: patient views and surgeon descriptions. European Journal of Cancer Care 2011;20:776-84.
21. Esserman LJ, Thompson Jr IM, Reid B. Overdiagnosis and overtreatment in cancer: An opportunity for improvement. Journal of the American Medical Association 2013;310:797-8.
22. Davey C, White V, Gattellari M, Ward JE. Reconciling population benefits and women's individual autonomy in mammographic screening: in-depth interviews to explore women's views about 'informed choice'. Australian and New Zealand Journal of Public Health 2005;29:69-77.
23. Politi MC, Han PKJ, Col NF. Communicating the Uncertainty of Harms and Benefits of Medical Interventions. Medical Decision Making 2007;27:681-95.
24. Department for Business Innovation and Skills. Skills for Life Survey: Headline findings. Research paper number 57 London: Department for Business Innovation and Skills, 2011.
25. Entwistle V, Carter S, Cribb A, McCaffery K. Supporting Patient Autonomy: The Importance of Clinician-patient Relationships. Journal of General Internal Medicine 2010;25:741-5.
26. Entwistle VA, Carter SM, Trevena L, et al. Communicating about screening. British Medical Journal 2008;337:789-91.
27. Forbes LJ and Ramirez AJ. Information about NHS Cancer Screening Programmes Consultation Report. http://www. informedchoiceaboutcancerscreening.org/wp-content/ uploads/2012/12/Report-of-consultation-on-informationabout- cancer-screening-programmes-13th-December- 2012_ls.pdf Accessed 18/06/2013: Informed Choice about Cancer Screening, King's Health Partners, 2012.
28. Akl EA, Oxman AD, Herrin J, et al. Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database of Systematic Reviews, 2011;3. Art. No.: CD006776. doi: 10.1002/14651858.CD006776.pub2.
29. Elwyn G, O'Connor AM, Bennett C, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLOS ONE 2009;4:e4705.
30. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, 2009, CD001431. doi: 10.1002/14651858.CD001431.pub2.
31. Charvet-Berard AI, Chopard P, Perneger TV. Measuring quality of patient information documents with an expanded EQIP scale. Patient Education & Counseling 2008;70:407-11.
32. Coulter A. Guidelines for developing good quality patient information. Informing patients: as assessment of the quality of patient information materials. London: King's Fund, 1998.
33. Coulter A. Engaging patients in healthcare. Maidenhead, England: Open University Press, 2011.
34. Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Helping Patients Decide: Ten Steps to Better Risk Communication. Journal of the National Cancer Institute 2011;103:1436-43.
35. Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. British Medical Journal 2003;327:741-4.
36. Forbes LJ, Ramirez AJ. Approach to developing information about NHS Cancer Screening Programmes. http:// www.informedchoiceaboutcancerscreening.org/wp-content/ uploads/2012/04/Approach-to-informed-choice-about- cancer-screening.pdf Accessed 18/06/2013: Informed Choice about Cancer Screening, King's Health Partners, 2012.
37. Khor Z. Citizens' Jury on information for women about breast screening. London: Office of Public Management, 2013.
38. Paul C, Nicholls R, Priest P, McGee R. Making policy decisions about population screening for breast cancer: The role of citizens' deliberation. Health Policy 2008;85: 314-20.
39. Campanelli P. Testing Survey Questions: New Directions in Cognitive Interviewing. Bulletin de Méthodologie Sociologique 1997;55:5-17.
40. Reyna VF. A Theory of Medical Decision Making and Health: Fuzzy Trace Theory. Medical Decision Making 2008;28:850-65.
41. Forbes LJ, Spika D. Evidence Resource about NHS Breast Screening. http://www.informedchoiceaboutcancer screening.org/wp-content/uploads/2013/05/Breast-screening -evidence-resource_Final.pdf Accessed 27/9/2013: Informed Choice about Cancer Screening, King's Health Partners, 2013.
42. Nicholls SG, Southern KW. Informed Choice for Newborn Blood Spot Screening in the United Kingdom: A Survey of Parental Perceptions. Pediatrics 2012;130: e1527-e33.